acetylcysteine has been researched along with Cruveilhier-Baumgarten Syndrome in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Liu, SR; Shi, TT; Wang, FG; Zhou, HP; Zhuang, RX | 1 |
| Colares, JR; da Silva, J; Fisher, C; Hartmann, RM; Licks, F; Marques, C; Marroni, NP; Reys, J; Schemitt, E; Soares, Mdo C | 1 |
| Anand, R; Fernando, B; Hamilton, G; Harry, D; Holt, S; Marley, R; Moore, K; Sanderson, P; Smith, R | 1 |
3 other study(ies) available for acetylcysteine and Cruveilhier-Baumgarten Syndrome
| Article | Year |
|---|---|
[The protective effect of N-acetylcysteine magnesium against liver cirrhosis with portal hypertension in rat].
Topics: Acetylcysteine; Animals; Hypertension, Portal; Liver Cirrhosis, Experimental; Male; Nitric Oxide; Rats; Rats, Sprague-Dawley; Transforming Growth Factor beta1 | 2012 |
N-acetylcysteine modulates angiogenesis and vasodilation in stomach such as DNA damage in blood of portal hypertensive rats.
Topics: Acetylcysteine; Animals; Antioxidants; Blotting, Western; Comet Assay; Disease Models, Animal; DNA Damage; Gastric Mucosa; Hypertension, Portal; Immunohistochemistry; Male; Neovascularization, Pathologic; Nitric Oxide Synthase Type III; Portal Pressure; Rats, Wistar; Stomach; Tyrosine; Vascular Endothelial Growth Factor A; Vasodilation | 2015 |
N-acetylcysteine prevents development of the hyperdynamic circulation in the portal hypertensive rat.
Topics: Acetylcysteine; Animals; Dinoprost; Hemodynamics; Hypertension, Portal; Male; Nitrates; Nitric Oxide; Nitrites; Oxidative Stress; Rats; Rats, Sprague-Dawley; Tumor Necrosis Factor-alpha | 1998 |